NCT06853106

Brief Summary

This randomized controlled trial (RCT) study aims to evaluate the effectiveness of a digital-based multimodal sleep management program compared to a waitlist control group in improving sleep-related outcomes, including insomnia severity, daytime sleepiness, objective sleep parameters, and sleep reactivity to stress, as well as psychological health indices, such as depression, anxiety, and resilience. Additionally, this study seeks to examine the mediating role of different chronotypes in the effectiveness of the sleep intervention on the outcomes of interest.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
15mo left

Started Apr 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Apr 2024Jul 2027

Study Start

First participant enrolled

April 24, 2024

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

February 20, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 28, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2027

Last Updated

February 28, 2025

Status Verified

February 1, 2025

Enrollment Period

2.8 years

First QC Date

February 20, 2025

Last Update Submit

February 24, 2025

Conditions

Keywords

AnxietyChronotypesDaytime SleepinessDepressionDigital-based Sleep ManagementInsomniaResilienceSleep ReactivityMindfulness-based Breathing

Outcome Measures

Primary Outcomes (1)

  • Insomnia Severity:The Insomnia Severity Index (ISI)

    The Insomnia Severity Index (ISI) consists of seven items that assess the current perception of the severity of three insomnia symptoms. Each item is rated on a 5-point Likert scale, with the total score ranging from 0 to 28. Higher scores indicate greater severity of insomnia.

    T0 = baseline; T1 = immediately after intervention; T2 = 4 weeks after intervention.

Secondary Outcomes (6)

  • Daytime Sleepiness:The Epworth Sleepiness Scale (ESS)

    T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention.

  • Sleep Parameters

    T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention

  • Sleep Reactivity: The Chinese version of the Ford Insomnia Response to Stress Test (FIRST)

    T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention

  • Resilience: The Chinese version of the Brief Resilience Scale (BRS)

    T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention

  • Depression: The Beck Depression Index II (BDI II)

    T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention

  • +1 more secondary outcomes

Other Outcomes (1)

  • Chronotype: The Chinese version of the Morningness-Eveningness Questionnaire (MEQ)

    T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention

Study Arms (2)

Waitlist control group

OTHER

Participants in the waitlist control group will maintain their daily routines without receiving any intervention throughout the experiment.

Other: Waitlist control group

digital-based multimodal sleep management program

EXPERIMENTAL

Participants in the experimental group will receive a 4-week digital-based multimodal sleep management program.

Behavioral: digital-based multimodal sleep management program

Interventions

The participants in the waitlist control group will be informed that they are on a waiting list during the intervention period, serving as a no-treatment control. They will receive the sleep intervention (i.e., the digital-based sleep management program) four weeks after the intervention period is completed.

Waitlist control group

The digital-based multimodal sleep management program consists of (1) sleep hygiene education, (2) sleep restriction, and (3) mindfulness breathing exercises. The program is internet-integrated and delivered via Google Meet, with 45-minute weekly sessions over four weeks. To increase participants' adherence to the sleep management program , the course instructor will request the participants to record their daily sleep diaries (time to bed, time to sleep, wake time during sleep and wake time) and sleep journals(practices of sleep hygiene, sleep restriction and mindfulness breathing exercise) in the mobile app for at least five consecutive days each week.

digital-based multimodal sleep management program

Eligibility Criteria

Age18 Years - 26 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Registered as a full-time student
  • Aged 18 to 26 years old
  • Experiencing insomnia for at least three months
  • Currently own and use a personal mobile device
  • Ability to read and speak Chinese
  • Not taking hypnotics, sedatives, or antidepressants
  • Not pregnant or lactating

You may not qualify if:

  • Using a smartphone model that cannot support the app
  • Currently using other sleep program apps
  • Meeting a STOP-BANG score of ≥3

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Medicine University

Taipei, 11031, Taiwan

RECRUITING

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersAnxiety DisordersDisorders of Excessive SomnolenceDepression

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersBehavioral SymptomsBehavior

Central Study Contacts

Pei-Shan Tsai, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
We will implement a double-masking protocol, ensuring that assessors and data collectors are all blinded to group assignments. Additionally, group assignments will also be masked from the data analyzer to minimize potential bias.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 20, 2025

First Posted

February 28, 2025

Study Start

April 24, 2024

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

July 31, 2027

Last Updated

February 28, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations